(Q40070362)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17923840%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

title

Vaccination against hepatitis C virus with dendritic cells transduced with an adenovirus encoding NS3 protein (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17923840%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

1 reference

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17923840%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Pablo Sarobe

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17923840%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

José-Ignacio Riezu-Boj

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17923840%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Juan José Lasarte

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17923840%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1

Aintzane Zabaleta

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17923840%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

2

Diana Llopiz

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17923840%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

4

Leyre Silva

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17923840%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Francisco Borrás-Cuesta

7

object named as

Francisco Borrás-Cuesta

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17923840%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

3

Laura Arribillaga

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17923840%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

9 October 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17923840%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17923840%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17923840%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17923840%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

210-217

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17923840%20AND%20SRC:MED&resulttype=core&format=json

Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif

8 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300333

7 January 2021

Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300333

7 January 2021

Cellular immunity to hepatitis C virus core protein and the response to interferon in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300333

7 January 2021

Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300333

7 January 2021

Production of interleukin-2 in response to synthetic peptides from hepatitis C virus E1 protein in patients with chronic hepatitis C: relationship with the response to interferon treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300333

7 January 2021

Determinants of viral clearance and persistence during acute hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300333

7 January 2021

Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300333

7 January 2021

Differential distribution and internal translation efficiency of hepatitis C virus quasispecies present in dendritic and liver cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300333

7 January 2021

Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300333

7 January 2021

Presence of functional dendritic cells in patients chronically infected with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300333

7 January 2021

Normal functional capacity in circulating myeloid and plasmacytoid dendritic cells in patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300333

7 January 2021

Comparable functions of plasmacytoid and monocyte-derived dendritic cells in chronic hepatitis C patients and healthy donors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300333

7 January 2021

Selective impairments in dendritic cell-associated function distinguish hepatitis C virus and HIV infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300333

7 January 2021

Reduced numbers and impaired ability of myeloid and plasmacytoid dendritic cells to polarize T helper cells in chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300333

7 January 2021

Isolation and functional analysis of circulating dendritic cells from hepatitis C virus (HCV) RNA-positive and HCV RNA-negative patients with chronic hepatitis C: role of antiviral therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300333

7 January 2021

Manipulating dendritic cell biology for the active immunotherapy of cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300333

7 January 2021

Therapeutic dendritic-cell vaccine for chronic HIV-1 infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300333

7 January 2021

Therapeutic Immunization with Dendritic Cells Loaded with Heat‐Inactivated Autologous HIV‐1 in Patients with Chronic HIV‐1 Infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300333

7 January 2021

Hepatitis C Virus Structural Proteins Impair Dendritic Cell Maturation and Inhibit In Vivo Induction of Cellular Immune Responses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300333

7 January 2021

Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300333

7 January 2021

Abnormal priming of CD4(+) T cells by dendritic cells expressing hepatitis C virus core and E1 proteins.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300333

7 January 2021

HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300333

7 January 2021

Genetic immunization and comprehensive screening approaches in HLA-A2 transgenic mice lead to the identification of three novel epitopes in hepatitis C virus NS3 antigen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300333

7 January 2021

Induction of primary human T cell responses against hepatitis C virus-derived antigens NS3 or core by autologous dendritic cells expressing hepatitis C virus antigens: potential for vaccine and immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300333

7 January 2021

Prophylactic and therapeutic vaccination with dendritic cells against hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300333

7 January 2021

Dendritic cells pulsed with hepatitis C virus NS3 protein induce immune responses and protection from infection with recombinant vaccinia virus expressing NS3.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300333

7 January 2021

Vaccination with protein-transduced dendritic cells elicits a sustained response to hepatitis C viral antigens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300333

7 January 2021

Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300333

7 January 2021

Recombinant adenovirus induces maturation of dendritic cells via an NF-kappaB-dependent pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300333

7 January 2021

Adenovirus-transduced dendritic cells stimulate cellular immunity to melanoma via a CD4(+) T cell-dependent mechanism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300333

7 January 2021

Vaccination with an adenoviral vector encoding hepatitis C virus (HCV) NS3 protein protects against infection with HCV-recombinant vaccinia virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300333

7 January 2021

Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300333

7 January 2021

Hepatitis C virus (HCV) specific immune responses in anti-HCV positive patients without hepatitis C viraemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300333

7 January 2021

HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300333

7 January 2021

Induction of antigen-specific immune responses in vivo after vaccination with dendritic cells transduced with adenoviral vectors encoding hepatitis C virus NS3.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300333

7 January 2021

Recombinant viruses as a tool for therapeutic vaccination against human cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300333

7 January 2021

Concerted action of the FasL/Fas and perforin/granzyme A and B pathways is mandatory for the development of early viral hepatitis but not for recovery from viral infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300333

7 January 2021

Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300333

7 January 2021

Induction of cytotoxic T-cell response against hepatitis C virus structural antigens using a defective recombinant adenovirus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300333

7 January 2021

Codon optimization and mRNA amplification effectively enhances the immunogenicity of the hepatitis C virus nonstructural 3/4A gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300333

7 January 2021

Upregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MT.6300333

7 January 2021

Identifiers

DOI

10.1038/SJ.MT.6300333

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17923840%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference